Ledger.Open graph →
SEC Form D · filed February 19, 2019

Eliem Therapeutics, Inc

Offering
$12.2M
Sold
$12.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David-Alexandre Gros · Ranchero Santa Fe, CADirectorSimon Tate · Cambridge, United KingdomDirectorJulio Vega · Boston, MAExecEdelweiss, LLC · SAN ANTONIO, TXDirectorJames R. Sechrist · NEWPORT BEACH, CADirectorAndrew Levin · BOSTON, MAExec · DirectorHarald Stock · Cambridge, MADirectorStephen L. Block · Los Angeles, CADirectorSteven T. Cornell · Salisbury, CTDirectorJulio Vega · Boston, MAExecAndrew Levin · Boston, MAExec · DirectorHarald Stock · Park City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗